Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Mon, 09/22/14 - 08:36 am
Tags:
Gilead Sciences, JNJ, Pharmacyclics, Imbruvica, Zydelig
Why Gilead Sciences Could Gain 30%
Barron's
Fri, 09/19/14 - 02:18 pm
Tags:
Gilead Sciences, SOF/LDV, hepatitis C
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thu, 09/18/14 - 12:03 pm
Tags:
Gilead Sciences, clinical trials, pancreatic cancer, simtuzumab
Dropout rate on $1,000-a-day pill jumps during transition to ‘real world’
Marketwatch
Wed, 09/17/14 - 04:32 pm
Tags:
Gilead Sciences, Sovaldi, drug pricing, hepatitis C
Gilead's oncology contender comes up short in pancreatic cancer
Fierce Biotech
Wed, 09/17/14 - 09:54 am
Tags:
Gilead Sciences, simtuzumab, pancreatic cancer
Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism
WSJ Pharmalot
Mon, 09/15/14 - 07:21 pm
Tags:
Gilead Sciences, drug pricing, hepatitis C, Sovaldi
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Mon, 09/15/14 - 11:36 am
Tags:
hepatitis C, Gilead Sciences, AbbVie, Achillion, Merck, Sovaldi, Idenix
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Mon, 09/15/14 - 08:49 am
Tags:
Gilead Sciences, Sovaldi, generics, hepatitis C, Cipla, Ranbaxy, Cadila, Mylan Labs, Strides Arcolab, Hetero Drugs, Sequent Scientific
Gilead Sciences: Sovaldi Sales Slip But Less Than Feared
Barron's
Fri, 09/12/14 - 06:58 pm
Tags:
Gilead Sciences, Sovaldi, hepatitis C
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wed, 09/10/14 - 11:33 am
Tags:
ViiV Healthcare, Gilead Sciences, HIV, Triumeq
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tue, 09/9/14 - 10:36 am
Tags:
GSK, Gilead Sciences, PAH, pulmonary arterial hypertension, Letairis, Adcirca
Can anything slow Gilead down? Analysts say no
CNBC
Mon, 09/8/14 - 08:16 pm
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Why Gilead Is Falling On Drugs For Developing Nations
Investor's.com
Sat, 09/6/14 - 09:17 am
Tags:
Gilead Sciences
Cheaper Version Of Gilead's Sovaldi Might Be On The Cards
Bidness Etc.
Fri, 09/5/14 - 08:05 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Gilead Close to Sending $84,000 Drug to Poor Countries
Bloomberg
Thu, 09/4/14 - 06:30 pm
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Fri, 08/29/14 - 08:10 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Tags:
Bristol-Myers Squibb, Gilead Sciences, hepatitis C, Daklinza, Sovaldi
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch
Investors.com
Wed, 08/27/14 - 09:55 am
Tags:
Jazz Pharmaceuticals, Gilead Sciences, Illumina, Salix
Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again
Yahoo/Zacks.com
Fri, 08/22/14 - 12:06 pm
Tags:
Gilead Sciences, earnings
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi
Yahoo/Zacks.com
Thu, 08/21/14 - 09:43 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.